Free Trial

Envista (NVST) Stock Price, News & Analysis

Envista logo
$17.49 +0.39 (+2.28%)
Closing price 04/2/2025 03:58 PM Eastern
Extended Trading
$17.50 +0.02 (+0.09%)
As of 04/2/2025 07:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Envista Stock (NYSE:NVST)

Key Stats

Today's Range
$16.79
$17.67
50-Day Range
$16.21
$22.12
52-Week Range
$15.15
$23.00
Volume
4.20 million shs
Average Volume
2.43 million shs
Market Capitalization
$3.01 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.18
Consensus Rating
Hold

Company Overview

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Remove Ads

Envista Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
85th Percentile Overall Score

NVST MarketRank™: 

Envista scored higher than 85% of companies evaluated by MarketBeat, and ranked 152nd out of 927 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Envista has received a consensus rating of Hold. The company's average rating score is 2.07, and is based on 3 buy ratings, 10 hold ratings, and 2 sell ratings.

  • Amount of Analyst Coverage

    Envista has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Envista's stock forecast and price target.
  • Earnings Growth

    Earnings for Envista are expected to grow by 21.00% in the coming year, from $1.00 to $1.21 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Envista is -2.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Envista is -2.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Envista has a PEG Ratio of 1.27. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Envista has a P/B Ratio of 1.03. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Envista's valuation and earnings.
  • Percentage of Shares Shorted

    4.78% of the float of Envista has been sold short.
  • Short Interest Ratio / Days to Cover

    Envista has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Envista has recently decreased by 4.80%, indicating that investor sentiment is improving.
  • Dividend Yield

    Envista does not currently pay a dividend.

  • Dividend Growth

    Envista does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.78% of the float of Envista has been sold short.
  • Short Interest Ratio / Days to Cover

    Envista has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Envista has recently decreased by 4.80%, indicating that investor sentiment is improving.
  • News Sentiment

    Envista has a news sentiment score of 1.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Envista this week, compared to 6 articles on an average week.
  • Search Interest

    2 people have searched for NVST on MarketBeat in the last 30 days.
  • MarketBeat Follows

    Only 1 people have added Envista to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Envista insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.30% of the stock of Envista is held by insiders.

  • Read more about Envista's insider trading history.
Receive NVST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Envista and its competitors with MarketBeat's FREE daily newsletter.

NVST Stock News Headlines

Envista Holdings (NVST) Receives a Buy from Evercore ISI
Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
Envista price target lowered to $21 from $23 at UBS
Envista price target lowered to $19 from $21 at Wells Fargo
Envista Holdings (NVST) Receives a Hold from J.P. Morgan
See More Headlines

NVST Stock Analysis - Frequently Asked Questions

Envista's stock was trading at $19.29 at the beginning of the year. Since then, NVST stock has decreased by 9.3% and is now trading at $17.49.
View the best growth stocks for 2025 here
.

Envista Holdings Co. (NYSE:NVST) announced its quarterly earnings results on Wednesday, February, 5th. The company reported $0.24 EPS for the quarter, topping analysts' consensus estimates of $0.23 by $0.01. Envista had a positive trailing twelve-month return on equity of 3.86% and a negative net margin of 44.56%.

Envista (NVST) raised $603 million in an initial public offering (IPO) on Wednesday, September 18th 2019. The company issued 26,800,000 shares at $21.00-$24.00 per share. J.P. Morgan, Goldman Sachs and Morgan Stanley served as the underwriters for the IPO and Baird, Evercore ISI, Jefferies, BofA Merrill Lynch, Credit Suisse, Stifel and William Blair were co-managers.

Shares of NVST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Envista investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH), The RMR Group (RMR) and AUO (AUOTY).

Company Calendar

Last Earnings
2/05/2025
Today
4/03/2025
Next Earnings (Estimated)
4/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Dental equipment & supplies
Sub-Industry
Medical Equipment
Current Symbol
NYSE:NVST
Employees
12,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$20.18
High Stock Price Target
$23.00
Low Stock Price Target
$17.50
Potential Upside/Downside
+15.4%
Consensus Rating
Hold
Rating Score (0-4)
2.07
Research Coverage
15 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
17.49
P/E Growth
1.27
Net Income
$-1,118,600,000.00
Pretax Margin
-43.21%

Debt

Sales & Book Value

Annual Sales
$2.51 billion
Cash Flow
$1.35 per share
Price / Cash Flow
12.91
Book Value
$17.04 per share
Price / Book
1.03

Miscellaneous

Free Float
169,950,000
Market Cap
$3.01 billion
Optionable
Optionable
Beta
1.33
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

This page (NYSE:NVST) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners